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The activities of UDP-glucuronyl transferase(s) in homogenates and microsomal preparations of human 
liver, kidney and intestine were tested with hyodeoxycholic acid (HDC). The various kinetic parameters of 
the UDC-glucuronidation were determined from time course experiments. In both liver and kidney prepara- 
tions, HDC underwent a very active metabolic transformation: liver K, = 78 PM, V,, = 3.3 nmol*min 
-l.rng -i protein; kidney K, = 186 PM, I’,, = 9.9 nmol.min -l.rng -l protein. To our knowledge this is 
the first observation of both an extensive and comparable bile acid glucuronidation occurring in renal and 
hepatic tissues. 
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1. INTRODUCTION 
In man and other animals, UDP-glucuronyl 
transferase(s) (UDP-GT) (EC 2.4.1.17) has been 
shown to be a very active enzyme in detoxification 
mechanisms [l]. It catalyzes the transfer of the ac- 
tivated form of glucuronic acid to a large variety of 
substrates, such as phenolic and naphtholic 
derivatives, morphine, menthol, testosterone, etc. 
[2] or bilirubin [3]. Different human organs com- 
monly possess UDP-GT activities, glucuronidation 
is observed in the liver [4], kidney [5] and intestine 
[6]. In 1974, Back et al. [7] were the first to detect 
the presence of bile salt glucuronides in the urine 
of man, thereafter the formation of bile acid 
glucuronides was described by several authors 
Abbreviations: HDC, hyodeoxycholic acid; UDP-GT, 
uridine diphosphate glucuronyl transferase; GLC, gas 
liquid chromatography; TLC, thin layer chromatog- 
raphy 
studying various pathologies (cholestasis, cirrhosis 
and intestinal malabsorption). 
Subsequently, Matern et al. [8,9] demonstrated 
UDP-GT activities on bile acids, in microsomal 
preparations of liver, kidney and intestine. In spite 
of these in vitro demonstrations of enzymatic ac- 
tivities, in vivo glucuronidation of bile acids re- 
mains a minor metabolic pathway. However, 
hyodeoxycholic acid (HDC), a 6 hydroxylated bile 
acid has been shown to be extensively 
glucuronidated and excreted in the urine of pa- 
tients [lo] and in healthy subjects [l l] after oral 
administration. A search for the organs responsi- 
ble for this extensive glucuronidation was 
therefore undertaken. 
2. MATERIALS AND METHODS 
2.1. Human samples 
Liver biopsies, or the whole organ, were ob- 
tained from human donors in an irreversible coma 
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(accident, suicide). Kidneys or fragments of in- 
testine were respectively obtained during nephrec- 
tomies (cancer) or ileal resections for Crohn’s 
disease or adenocarcinoma. The liver and kidney 
specimens were immediately sliced into thin pieces, 
frozen in liquid NZ and then stored at - 70°C. In- 
testinal mucosa was prepared as described by 
Weiser [12]. Histological studies of the tissues used 
were made to ensure that they were normal. 20% 
homogenates (w/v) were prepared with sucrose 
(0.3 M) using a glass homogenizer with a teflon 
pestle and microsomal preparations were obtained 
after centrifugation of the post mitochondrial 
supernatants at 105000 x g for 60 min. The final 
pellets were resuspended in 0.3 M sucrose contain- 
ing 15 mM Tris-HCl (pH 7.5). 
2.2. Analytical procedure 
Labelled [24-14C]HDC was prepared by extrac- 
tion from the faeces of Fischer rats, which had in- 
gested [24-‘4C]chenodeoxycholic acid [lo], and 
then purified by separation on a silica gel column. 
The UDP-GT activity was measured by incuba- 
tion, at 37”C, of the hepatic, renal and ileal 
homogenates or microsomal proteins (1 mg) in a 
reaction mixture containing UDP-glucuronic acid 
(3 mM), MgC12 (5 mM), delipidated bovine 
albumin (7.5 PM), [24-14C]HDC (40 PM, spec. act. 
1.18 pCi/pmol), with or without Brij 58 
(0.5 mg/mg protein added). The reaction was 
stopped at different times by adding 1 ml cold 
methanol. The proportion of HDC metabolite was 
determined by TLC of the medium on silica gel us- 
ing butanol-acetic acid-water 10: 1: 1 (v/v) as sol- 
vent (system I) and then by examination of the 
plates with a Berthold radioscanner. 
The HDC metabolite was identified by TLC of 
the bile acid in system I or TLC of the methylated 
derivative using chloroform-acetone-methanol 
70: 25 : 5 (v/v) (system II) as the solvent. 
Glucuronide was hydrolyzed using a p- 
glucuronidase isolated from Escherichia coli under 
the following conditions: a microsomal incubation 
(as described above) was lyophylised and diluted in 
1 ml phosphate buffer (4 mM, pH 6.8) containing 
100 Sigma units of ,,&glucuronidase. Hydrolysis 
was continued for 20 h at 37°C. The medium was 
then acidified to pH 1 with 6 M HCI, extracted 
with ether and evaporated to dryness. Extracts 
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were methylated with diazomethane, fractionated 
on TLC (system II) and analysed with a Berthold 
radioscanner. For GLC analyses, extracts were 
methylated and trifluoroacetylated with trifluoro- 
acetic anhydride and injected into the glass column 
(1 = 1.5 m, i.d. = 3 mm) of a 7400 Packard 
chromatograph. Injections were made using a solid 
injector at a temperature of 210°C the column 
was packed with a 2% OV 210 fixed on Gas Chrom 
Q 100-200 mesh as stationary phase. 
2.3. Chemicals 
[24-14C]Chenodeoxycholic a id (50 mCi/mmol) 
was purchased from NEN Chemicals (Boston, 
USA) %nd the unlabelled compound from Serva 
(Heidelberg, FRG). UDP-glucuronic acid, Brij 58, 
sucrose, fi-glucuronidase (E. ~011) and free lipid 
albumin were obtained from Sigma (St. Louis, 
MO) and saccharolactone from Calbiochem- 
Behring (San Diego, CA). Diazald was obtained 
from Ega-Chemie (Steinheim, FRG) and trifluoro- 
acetic anhydride from Merck (Darmstadt, FRG). 
3. RESULTS AND DISCUSSION 
3. I. Hepatic glucuronidation 
Both liver homogenates and microsomal 
preparations actively transformed HDC into its 
corresponding glucuronide. The proportion of 
synthesized glucuronide after 60 min incubation, 
varied from 25% in homogenates to 81% in 
microsomal preparations (fig. 1). The activities of 
both preparations were increased when the 
detergent Brij 58 was added (fig. 1). These observa- 
tions may be related to the location of UDP-GT in 
the endoplasmic reticulum of hepatocytes [l] and 
to the known activation of membrane bound en- 
zyme by compounds which alter the phospholipid 
environment [131. Another parameter which could 
have caused variations or underestimations of the 
HDC glucuronidation is the reverse reaction by 
hepatic P-glucuronidase. Experiments were 
therefore carried out using saccharolactone, an in- 
hibitor of this enzyme. No effects on the rate of 
HDC-glucuronidation or on the proportion of 
HDC glucuronide formed were observed, even 
when the concentration of inhibitor reached 
lo-times that of HDC. 
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Fig.1. Time courses of HDC glucuronidation in 
preparations of hepatic human tissues. 1 mg of either 
homogenate (H) or microsomal proteins (M) were 
incubated with [24-14C]HDC (4OrM) and UDP- 
glucuronic acid (3 mM). UDP-glucuronyl-transferase 
activity was measured with (+) or without (- ) the 
detergent Brij 58. 
3.2. Comparison between the different organs 
Time courses of HDC glucuronidation in kidney 
homogenates and microsomal preparations are 
presented in fig.2. 
The UDP-GT activity observed in this organ was 
similar to that of the liver tissues. The same dif- 
ferences were observed between homogenates and 
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Fig.2. Time courses of HDC glucuronidation in 
preparations of renal human tissues. Experimental 
conditions were identical to those used in liver 
preparations (see text). M and H represent microsomal 
and homogenate preparations, + and - indicate the 
Fig.3. Lineweaver-Burk plots of HDC glucuronidation 
in the liver and kidney. Microsomal proteins (1 mg) of 
different tissues were incubated with Brij 58 (0.5 mg) at 
various known concentrations of [24-14C]HDC. 
Incubations were stopped after 15 min and the 
proportion of HDC glucuronide determined (see section 
presence or absence of detergent Brij 58. 2.2). 
mrcrosomal preparations, and the UDP-GT activi- 
ty was increased by detergent reatment (Brij ,58). 
These results are in agreement with a microsomal 
location of renal HDC-UDP-GT activity. 
Lineweaver-Burk plot (fig.3) for hepatic and renal 
UDP-GT activities gave 2 straight lines from which 
the apparent K, and Vmax were calculated: liver 
K, = 78pM, V,,, = 3.3 nmol.min-‘srng-’ pro- 
tein and kidney K,,, = 186 FM, Vmax = 
9.9 nmol-min-‘mrng-’ protein. Such a level of 
renal UDP-GT activity for bile acids has never 
been observed in normal human tissues. This fact 
could account for the important urinary excretion 
of HDC glucuronide seen in patients with T-tubes 
[lo] and in healthy subjects [l 11, after HDC oral 
administration. 
The glucuronidation of HDC in the ileum oc- 
curred at a lower rate than in other organs (fig.4) 
and was not increased by the addition of Brij 58. 
3.3. Comparison with chenodeoxycholic acid 
Time courses experiments comparing the 
glucuronidation of HDC and chenodeoxycholic 
acid were conducted under identical experimental 
conditions. Wide variations were observed be- 
tween the substrates (fig.5). In both the liver and 
kidney preparations, HDC undergoes a more ac- 
tive glucuronidation than chenodeoxycholic acid. 
185 
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Fig.4. Time courses of HDC glucuronidation in ileal 
preparations of human intestine. Incubations were 
carried out (as described in section 2.2) on homogenates 
of mucosa cells with ( + ) or without ( - ) the detergent 
Brij 58. 
It is interesting to note that a slight modification in 
the chemical structure of these bile acids (i.e. HDC 
is dihydroxylated in 3~ and & positions and 
chenodeoxycholic acid in 3~, 7~) should produce 
such variations in UDP-GT activity. 
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Fig.5. Comparison of HDC and chenodeoxycholic acid 
glucuronidation in the liver and kidney. HL, HDC in 
liver; CL, chenodeoxycholic acid in liver; HK, HDC in 
kidney; CK, chenodeoxycholic acid in kidney. 1 mg 
microsomal preparations were incubated with the 
detergent Brij 58. The percentages of the 2 bile acid 
glucuronides were measured at 2 different times. 
3 4. of HDC glucuronide 
The metabolic transformations of HDC by 
hepatic and renal tissues, have produced only one 
compound whose Rf (0.40) on silica gel plates with 
system I as solvent, clearly discriminated it from 
HDC (Rf = 0.93). This metabolite possessed the 
same Rf as the glucuronide isolated from urine of 
healthy subjects after oral administration of HDC 
[ 111. In addition, fl-glucuronidase treatment of the 
incubation medium (containing 70-94% of HDC 
metabolite) produced a single radioactive com- 
pound. Its characterization was achieved by com- 
paring migration (plates, system II) of a HDC 
methyl ester (standard) with the methylated 
derivative and by GLC analysis of the 
trifluor%acetylated methyl ester derivatives. 
Equivalent structural determinations were ob- 
tained from ileal homogenates although the pro- 
portion of glucuronide (15%) was lower. 
It is possible to conclude that HDC undergoes 
no biotransformation, in these in vitro ex- 
periments, other than glucuronidation. In par- 
ticular, no modification of the initial steroid struc- 
ture of HDC (hydroxylation, oxidation, etc.) was 
detected, in the microsomal preparations. 
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